Haleon (NYSE:HLN) Sets New 1-Year High at $9.94

Shares of Haleon plc (NYSE:HLN) reached a new 52-week high during trading on Tuesday . The company traded as high as $9.94 and last traded at $9.94, with a volume of 312637 shares. The stock had previously closed at $9.87.

Analyst Upgrades and Downgrades

A number of research firms recently commented on HLN. Berenberg Bank began coverage on shares of Haleon in a report on Tuesday, August 6th. They set a “buy” rating on the stock. The Goldman Sachs Group downgraded shares of Haleon from a “buy” rating to a “neutral” rating in a report on Tuesday, August 6th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy”.

Haleon Trading Up 0.2 %

The company has a debt-to-equity ratio of 0.53, a current ratio of 1.04 and a quick ratio of 0.73. The company has a market cap of $45.62 billion, a price-to-earnings ratio of 33.30, a PEG ratio of 2.69 and a beta of 0.24. The business’s 50-day simple moving average is $9.13 and its 200-day simple moving average is $8.62.

Haleon (NYSE:HLN) last announced its earnings results on Thursday, August 1st. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.01). The business had revenue of $3.50 billion for the quarter, compared to analyst estimates of $3.55 billion. Haleon had a return on equity of 19.85% and a net margin of 9.71%. During the same quarter in the previous year, the firm posted $0.08 EPS. Research analysts predict that Haleon plc will post 0.47 earnings per share for the current fiscal year.

Haleon Cuts Dividend

The company also recently disclosed a semi-annual dividend, which will be paid on Thursday, September 19th. Stockholders of record on Friday, August 16th will be given a $0.0514 dividend. This represents a dividend yield of 1.6%. The ex-dividend date is Friday, August 16th. Haleon’s dividend payout ratio is presently 33.33%.

Hedge Funds Weigh In On Haleon

A number of institutional investors have recently modified their holdings of HLN. Hexagon Capital Partners LLC raised its position in shares of Haleon by 107.3% in the fourth quarter. Hexagon Capital Partners LLC now owns 4,236 shares of the company’s stock valued at $35,000 after buying an additional 2,193 shares during the last quarter. Cultivar Capital Inc. acquired a new position in shares of Haleon in the second quarter valued at approximately $40,000. Allspring Global Investments Holdings LLC acquired a new position in shares of Haleon in the first quarter valued at approximately $43,000. Tower Research Capital LLC TRC raised its position in shares of Haleon by 146.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,398 shares of the company’s stock valued at $44,000 after buying an additional 3,211 shares during the last quarter. Finally, SRS Capital Advisors Inc. raised its position in shares of Haleon by 456.4% in the fourth quarter. SRS Capital Advisors Inc. now owns 5,458 shares of the company’s stock valued at $45,000 after buying an additional 4,477 shares during the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.